Meeting
2024 ASCO Gastrointestinal Cancers Symposium
An observational study on treatment patterns and outcomes among patients with metastatic or recurrent esophageal cancer: Real-world data and empirical analyses in Japan (POME).
Presenter
Shun Yamamoto, MD
Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 289)
DOI
10.1200/JCO.2024.42.3_suppl.289
Abstract #
289
Poster Bd #
D9
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2020 ASCO Virtual Scientific Program
HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.
Speaker: Andreas Dietz
Videos & Slides
2024 ASCO Gastrointestinal Cancers Symposium
A randomized phase III study comparing 2-weekly docetaxel, cisplatin and 5-FU (bDCF) with cisplatin and 5-FU (CF) in patients with metastatic or recurrent esophageal cancer: JCOG1314 (MIRACLE).
Speaker: Takahiro Tsushima, MD, PhD
Videos & Slides
2021 Gastrointestinal Cancers Symposium
Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.
Speaker: Laura Miotke
Videos & Slides
2020 ASCO Virtual Scientific Program
Impact of body measurements (BM) on overall survival (OS) and quality of life (QoL) in real-world patients (pts) with metastatic esophageal cancer.
Speaker: Joelle Soriano